Last Updated on November 26, 2024 by The Health Master
Drug recall
Lupin Pharmaceuticals Inc., a US subsidiary of India’s Lupin, has initiated a voluntary drug recall of over 600,000 bottles of Ramipril capsules in the United States.
The reason behind this drug recall is a serious manufacturing issue: the active pharmaceutical ingredient (API) was sourced from an unapproved vendor, violating current Good Manufacturing Practices (CGMP).
What Does This Mean for Patients?
If you’re currently taking Ramipril, it’s crucial to consult with your healthcare provider.
They can advise you on whether you need to switch medications or if your current prescription is unaffected by the drug recall.
Dr. Reddy’s Also Faces Drug Recall
In another development, Dr. Reddy’s Laboratories, a leading global pharmaceutical company, has also issued a drug recall for its Ibuprofen 600 mg tablets.
This drug recall is due to failed tablet specifications, which could potentially impact the product’s efficacy and safety.
Understanding Drug Recall Classifications
- Class II Drug Recall: This is a serious drug recall, as the use or exposure to the product may cause temporary or medically reversible adverse health consequences.
- Class III Drug Recall: While less severe, a Class III drug recall still necessitates action. The use or exposure to the product is not likely to cause adverse health consequences.
Key Takeaways:
- Lupin is recalling Ramipril capsules due to a CGMP violation.
- Dr. Reddy’s is recalling Ibuprofen tablets due to failed specifications.
- Patients should consult with their healthcare providers for further guidance.
- Stay updated on the latest information from the USFDA and the respective pharmaceutical companies.
By staying informed and taking appropriate steps, you can protect your health and well-being.
-
Why are these recalls happening?
Both Lupin and Dr. Reddy’s have encountered manufacturing issues that do not meet US FDA standards.
-
What should I do if I’m taking a recalled medication?
Contact your healthcare provider for guidance. They will advise you on the best course of action.
-
Is this a widespread issue?
While these recalls are significant, they are specific to certain products and batches. It’s essential to stay informed and follow the advice of healthcare professionals.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Disclaimer: This content, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. The Health Master does not claim responsibility for this information.
Drug recall: Cipla recalls over 1.8k boxes of this drug
Drug recall: Dr Reddy’s, FDC recall drugs: A Closer Look
Drug recall: Ascorbic Acid Injection recalled due to this reason
Drug recall: Dr Reddy’s recalls Cinacalcet Tablets due to impurity Concerns
Drug recall: Gilead recalled this drug after failed trial
Drug recall: Glenmark recalls drugs for manufacturing issues
FSSAI: Food Labelling and Display – Chapter-12
USFDA issued Form 483 with 5 observations to Alembic
India to ease Regulations for Stem Cell and Gene Therapy product manufacturing
State Demands National Portal to Track Fake Drugs
NPPA recalculates Ceiling Price of Atorvastatin 10mg
Fire explosion at Aurore Pharmaceuticals
Drug recall: Cipla recalls over 1.8k boxes of this drug
USFDA issued Form 483 with 7 observations to Dr Reddy’s
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
